Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial
Bosaeed, Mohammad, Balkhy, Hanan H, Almaziad, Sultan, Aljami, Haya A, Alhatmi, Hind, Alanazi, Hala, Alahmadi, Mashael, Jawhary, Ayah, Alenazi, Mohammed W, Almasoud, Abdulrahman, Alanazi, Rawan, Bittaye, Mustapha, Aboagye, Jeremy, Albaalharith, Nahla, Batawi, Sarah, Folegatti, Pedro, Ramos Lopez, Fernando, Ewer, Katie, Almoaikel, Khalid, Aljeraisy, Majed, Alothman, Adel, Gilbert, Sarah C, Khalaf Alharbi, Naif
Published in The Lancet. Microbe (01.01.2022)
Published in The Lancet. Microbe (01.01.2022)
Get full text
Journal Article
Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial
Bosaeed, Mohammad, Alharbi, Ahmad, Mahmoud, Ebrahim, Alrehily, Sanaa, Bahlaq, Mohannad, Gaifer, Zied, Alturkistani, Hanan, Alhagan, Khaled, Alshahrani, Saad, Tolbah, Ali, Musattat, Abrar, Alanazi, Maha, Jaha, Raniah, Sultana, Khizra, Alqahtani, Hajar, Al Aamer, Kholoud, Jaser, Saud, Alsaedy, Abdulrahman, Ahmad, Ayoub, Abalkhail, Mohammed, AlJohani, Sameera, Al Jeraisy, Majed, Almaziad, Sultan, Albaalharith, Nahlah, Alabdulkareem, Khaled, Alshowair, Abdulmajeed, Alharbi, Naif Khalaf, Alrabiah, Fahad, Alshamrani, Majid, Aldibasi, Omar, Alaskar, Ahmed
Published in Clinical microbiology and infection (01.04.2022)
Published in Clinical microbiology and infection (01.04.2022)
Get full text
Journal Article